Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial (Q58229257)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial |
article |
Statements
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial (English)
Allison Steigler
Chantelle Wilcox
David S Lamb
David Joseph
Chris Atkinson
John Matthews
Keen-Hun Tai
Nigel A Spry
Paul S Gleeson
Catherine D'Este
Trans-Tasman Radiation Oncology Group 96.01 Trialists
15 October 2008